Indaptus Therapeutics, Inc. (INDP)
NASDAQ: INDP · IEX Real-Time Price · USD
2.440
0.00 (0.00%)
Apr 5, 2024, 3:59 PM EDT - Market open

Indaptus Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year 2023202220212020201920182017201620152014 2013
Selling, General & Admin
8.768.595.210.948.297.935.143.12.792.61
Upgrade
Research & Development
7.626.322.522.6626.6635.424.310.754.823.41
Upgrade
Other Operating Expenses
000012.1600-0.03-0.02-0.23
Upgrade
Operating Expenses
16.3814.917.733.647.1143.3329.4413.817.585.78
Upgrade
Operating Income
-16.38-14.91-7.73-3.6-47.11-43.33-29.44-13.81-7.58-5.78
Upgrade
Interest Expense / Income
0000-0.150.11-0.560.020.230.23
Upgrade
Other Expense / Income
-0.96-0.59-0.02-0.02----0.47-0.630.49
Upgrade
Pretax Income
-15.42-14.32-7.71-3.58-46.96-43.44-28.88-13.36-7.18-6.5
Upgrade
Income Tax
00000.640.10.03000
Upgrade
Net Income
-15.42-14.32-7.71-3.58-47.6-43.54-28.91-13.36-7.18-6.5
Upgrade
Shares Outstanding (Basic)
8842000000
Upgrade
Shares Outstanding (Diluted)
8842000---
Upgrade
Shares Change
1.68%101.98%110.35%360.55%8.29%76.63%54.26%13.24%--
Upgrade
EPS (Basic)
-1.83-1.73-1.89-1.84-112.72-112.00-131.20-93.60-73.60-94.40
Upgrade
EPS (Diluted)
-1.83-1.73-1.89-1.84-112.72-112.00-131.20-93.60-73.60-94.40
Upgrade
Free Cash Flow
-13.41-12.91-10.84-3.32-29.97-43.74-27.13-12.49-9.32-4.83
Upgrade
Free Cash Flow Per Share
-1.60-1.56-2.65-1.71-70.97-112.19-122.88-87.26-73.71-38.20
Upgrade
EBITDA
-15.42-14.32-7.71-3.58-46.26-42.47-28.61-13.35-6.95-6.27
Upgrade
Depreciation & Amortization
00000.850.860.83000
Upgrade
EBIT
-15.42-14.32-7.71-3.58-47.11-43.33-29.44-13.35-6.95-6.27
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).